John Marcolini Sells 1,074 Shares of Itron (NASDAQ:ITRI) Stock

Itron, Inc. (NASDAQ:ITRI) SVP John Marcolini sold 1,074 shares of the company’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $100.17, for a total value of $107,582.58. Following the completion of the sale, the senior vice president owned 25,838 shares of the company’s stock, valued at $2,588,192.46. This trade represents a 3.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Itron Price Performance

Shares of ITRI stock traded down $4.33 during mid-day trading on Monday, hitting $95.21. 2,762,408 shares of the stock traded hands, compared to its average volume of 824,922. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.56 and a current ratio of 1.80. The firm has a market cap of $4.28 billion, a price-to-earnings ratio of 14.63, a price-to-earnings-growth ratio of 0.86 and a beta of 1.48. The company’s 50-day simple moving average is $97.72 and its 200-day simple moving average is $109.93. Itron, Inc. has a twelve month low of $88.57 and a twelve month high of $142.00.

Itron (NASDAQ:ITRI) last announced its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.19 by $0.27. Itron had a return on equity of 20.04% and a net margin of 12.72%.The business had revenue of $571.66 million during the quarter, compared to analysts’ expectations of $561.31 million. During the same quarter last year, the business posted $1.35 earnings per share. The company’s quarterly revenue was down 6.7% on a year-over-year basis. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. As a group, equities research analysts expect that Itron, Inc. will post 5.33 earnings per share for the current year.

Hedge Funds Weigh In On Itron

A number of large investors have recently made changes to their positions in the business. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of Itron during the second quarter worth approximately $30,000. Bessemer Group Inc. increased its stake in Itron by 125.7% in the 2nd quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company’s stock valued at $34,000 after buying an additional 142 shares during the period. Employees Retirement System of Texas purchased a new stake in Itron in the 3rd quarter worth approximately $32,000. Private Trust Co. NA boosted its stake in shares of Itron by 112.4% during the 4th quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock valued at $25,000 after buying an additional 145 shares during the period. Finally, Optiver Holding B.V. purchased a new position in shares of Itron during the 3rd quarter valued at $36,000. Institutional investors and hedge funds own 96.19% of the company’s stock.

Itron News Roundup

Here are the key news stories impacting Itron this week:

• Neutral Sentiment: Itron announced a $600.0 million offering of convertible senior notes — this raises cash but can be dilutive if converted; market reaction depends on use of proceeds and conversion terms. Itron Announces $600.0 Million Convertible Senior Notes
• Negative Sentiment: SVP Christopher E. Ware sold 4,486 shares at ~$99.54 (reducing his stake ~12.36%). Form 4 – Christopher E. Ware
• Negative Sentiment: SVP Donald L. Reeves III sold 5,419 shares at ~$99.54 (reducing his stake ~14.05%). Form 4 – Donald L. Reeves III
• Negative Sentiment: SVP Laurie Ann Pulatie‑Hahn sold 3,755 shares at ~$99.54 (reducing her stake ~10.03%). Form 4 – Laurie Ann Pulatie‑Hahn
• Negative Sentiment: SVP Justin K. Patrick sold 4,930 shares at ~$99.54 (reducing his stake ~12.55%). Form 4 – Justin K. Patrick
• Negative Sentiment: SVP John F. Marcolini sold 6,948 shares at ~$99.54 (reducing his stake ~20.52%). Form 4 – John F. Marcolini
• Negative Sentiment: CFO Joan S. Hooper sold 15,293 shares at ~$99.54 (reducing her stake ~10.96%); a CFO sale of this size is often viewed negatively by investors. Form 4 – Joan S. Hooper

Analysts Set New Price Targets

Several research firms have issued reports on ITRI. Zacks Research cut Itron from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 28th. Wall Street Zen downgraded Itron from a “buy” rating to a “hold” rating in a report on Wednesday, January 14th. Robert W. Baird set a $128.00 price objective on Itron and gave the stock an “outperform” rating in a report on Wednesday, February 18th. Oppenheimer raised their target price on shares of Itron from $125.00 to $133.00 and gave the stock an “outperform” rating in a report on Wednesday, February 18th. Finally, Guggenheim set a $155.00 price target on shares of Itron in a report on Friday, February 13th. Eight equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $137.90.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.